1611603463.png)
On Jan. 25-26, the Society for Maternal-Fetal Medicine (SMFM) and the Preeclampsia Foundation will bring together leading national and international clinicians and researchers for an in-depth look at how to better predict, prevent, and manage preecla...
The Preeclampsia Foundation is urgently calling for the development of biomarker tests for simple, rapid, and accurate diagnosis and prediction of preeclampsia, a life-threatening hypertensive disorder of pregnancy. This call-to-action statement reco...
1590071425.png)
Cuff Kit program launched.
This article was originally written in 2013, but is still especially relevant today on National Nurses Day during the COVID-19 pandemic. Thank you to all the many nurses and midwives in our community who do what is best for their patients! In 2013,...
Foundation joins Brigham and Women’s investigators on important research study Preeclampsia puts women at increased risk for heart disease as well as stroke and high blood pressure later in life. Large population studies have demonstrated that...
This is a great day for preeclampsia and the beginning of the end of needless deaths. Late last night, President Trump signed into law the Preventing Maternal Deaths Act. We are very proud and incredibly thankful! This legislation will directly impac...
Melbourne, Florida – December 12, 2018 – The Preeclampsia Foundation is pleased to announce MoMMA’s Voices, a national coalition of patient organizations and individuals with lived experiences or those who represent them, using thei...
Data from nine states’ Maternal Mortality Review Committees (MMRCs) has been collected and analyzed under the “Building U.S. Capacity to Review and Prevent Maternal Deaths” project. For the first time, this report includes recommend...
At the Preeclampsia Foundation, we work diligently to inform expectant parents of the signs and symptoms of preeclampsia so they recognize and respond appropriately to them. An educated patient can sometimes make the difference between life and death...
A new study recently published by the New England Journal of Medicine found that women at high risk for preterm preeclampsia who took aspirin were less likely to develop the condition than women who were given a placebo. Women from 13 different hosp...
Preeclampsia Foundation Statement on AJOG Preeclampsia Report of Major Impact Melbourne, FL – Eleni Tsigas, Executive Director of the Preeclampsia Foundation, released the following statement on the American Journal of Obstetrics & Gynecol...
States and healthcare systems that are making a concerted effort to respond to the alarming maternal mortality and morbidity rate in this country are discovering something important. Neglect, delayed diagnosis, and inadequate management contributed t...